MRD in ALL: Optimization and Innovations

Pierce, E; Mautner, B; Mort, J; Blewett, A; Morris, A; Keng, M; El Chaer, F

El Chaer, F (通讯作者),Univ Virginia, Ctr Comprehens Canc, Div Hematol & Oncol, Dept Med, 1300 Jefferson Pk Ave,POB 800716, Charlottesville, VA 22908 USA.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022; 17 (4): 69

Abstract

Purpose of Review Measurable residual disease (MRD) is an important monitoring parameter that can help predict survival outcomes in acute lymphoblasti......

Full Text Link